Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial
Titel:
Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial
Auteur:
Ritchlin, Christopher T Kavanaugh, Arthur Merola, Joseph F Schett, Georg Scher, Jose U Warren, Richard B Gottlieb, Alice B Assudani, Deepak Bedford-Rice, Kathy Coarse, Jason Ink, Barbara McInnes, Iain B